EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer

• Stephanie Rossnagl,

  Affiliations Max-Planck Institute of Biochemistry, Martinsried, Germany, Institute of Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Eva Altrock,

  Affiliations Max-Planck Institute of Biochemistry, Martinsried, Germany, Institute of Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Carla Sens,

  Affiliations Max-Planck Institute of Biochemistry, Martinsried, Germany, Institute of Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Sabrina Kraft,

  Affiliations Max-Planck Institute of Biochemistry, Martinsried, Germany, Institute of Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Katrin Rau,

  Affiliations Max-Planck Institute of Biochemistry, Martinsried, Germany, Institute of Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Michael D. Milsom,

  Affiliation German Cancer Research Center (DKFZ), Division of Stem Cells and Cancer, Experimental Hematology Group, and Heidelberg Institute for Stem Cell Technology and Experimental Medicine, gGmbH (HI-STEM), Heidelberg, Germany

  http://orcid.org/0000-0002-3567-254X

  ⨯
• Thomas Giese,

  Affiliation Institute of Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Yvonne Samstag,

  Affiliation Institute of Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Inaam A. Nakchbandi

  * E-mail: inaam.nakchbandi@immu.uni-heidelberg.de

  Affiliations Max-Planck Institute of Biochemistry, Martinsried, Germany, Institute of Immunology, University of Heidelberg, Heidelberg, Germany

  ⨯